Upregulation of I-CAM1 in response to beryllium exposure in small airway epithelial cells

Toxicology Letters

Volumn 179, Issue 3, 2008, Pages 140-147

  Rodriguez, Shannan ^a,b   Kunde, Yuliya A ^a   McCleskey, T Mark ^a   Hong Geller, Elizabeth ^a  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

^b Northern New Mexico College   (United States)

Author keywords

Beryllium; Chronic Beryllium Disease; I CAM; Immune response; Lung epithelial cells

Indexed keywords

BERYLLIUM SULFATE; CELL ADHESION MOLECULE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE SYK;

ARTICLE; BERYLLIOSIS; CELL ADHESION; CELL STIMULATION; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HYPERSENSITIVITY; IMMUNE RESPONSE; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY EPITHELIUM; UPREGULATION;

ANTIBODIES, BLOCKING; BERYLLIUM; BRONCHI; CELL ADHESION; CELLS, CULTURED; HUMANS; IMMUNITY, MUCOSAL; INTERCELLULAR ADHESION MOLECULE-1; RESPIRATORY MUCOSA; RNA, MESSENGER; STILBENES; UP-REGULATION;

EID: 45849094802     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2008.04.014     Document Type: Article

References (45)

1. Amin M.A., Haas C.S., Zhu K., Mansfield P.J., Kim M.J., Lackowski N.P., and Koch A.E. Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NFkappaB. Blood 107 (2006) 2252-2261
2. Bals R., and Hiemstra P.S. Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur. Respir. J. 23 (2004) 327-333
3. Baumer I., Zissel G., Schlaak M., and Muller-Quernheim J. Shed soluble ICAM-1 molecules in bronchoalveolar lavage cell supernatants and serum of patients with pulmonary sarcoidosis. Lung 175 (1997) 105-116
4. Baumer I., Zissel G., Schlaak M., and Muller-Quernheim J. Soluble intercellular adhesion molecule 1 (sICAM-1) in bronchoalveolar lavage (BAL) cell cultures and in the circulation of patients with tuberculosis, hypersensitivity pneumonitis and sarcoidosis. Eur. J. Med. Res. 3 (1998) 288-294
5. Beck-Schimmer B., Schimmer R.C., and Pasch T. The airway compartment: chambers of secrets. News Physiol. Sci. 19 (2004) 129-132
6. Bocker U., Yezerskyy O., Feick P., Manigold T., Panja A., Kalina U., Herweck F., Rossol S., and Singer M.V. Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with Toll-like receptor 4 but not Toll-like receptor 2 or CD14 expression. Int. J. Colorectal. Dis. 18 (2003) 25-32
7. Camussi G., Albano E., Tetta C., and Bussolino F. The molecular action of tumor necrosis factor-alpha. Eur. J. Biochem. 202 (1991) 3-14
8. Chou Y.K., Edwards D.M., Weinberg A.D., Vandenbark A.A., Kotzin B.L., Fontenot A.P., and Burrows G.G. Activation pathways implicate anti-HLA-DP and anti-LFA-1 antibodies as lead candidates for intervention in chronic berylliosis. J. Immunol. 174 (2005) 4316-4324
9. Fontenot A., Falta M., Newman L., and Kotzin B. Identification of pathogenic T cells in patients with beryllium-induced lung disease. J. Immunol. 163 (1999) 1019-1026
10. Fontenot A.P., Edwards D.M., Chou Y.K., Mack D.G., Latocha D., Vandenbark A.A., and Burrows G.G. Self-presentation of beryllium by BAL CD4+ T cells: T cell-T cell interactions and their potential role in chronic beryllium disease. Eur. J. Immunol. 36 (2006) 930-939
11. Fontenot A.P., and Maier L.A. Genetic susceptibility and immune-mediated destruction in beryllium-induced disease. Trends Immunol. 26 (2005) 543-549
12. Grothey A., Heistermann P., Philippou S., and Voigtmann R. Serum levels of soluble intercellular adhesion molecule-1 (ICAM-1, CD54) in patients with non-small-cell lung cancer: correlation with histological expression of ICAM-1 and tumour stage. Br. J. Cancer 77 (1998) 801-807
13. Hippenstiel S., Opitz B., Schmeck B., and Suttorp N. Lung epithelium as a sentinel and effector system in pneumonia-molecular mechanisms of pathogen recognition and signal transduction. Respir. Res. 7 (2006) 97
14. Hong-Geller E., Pardington P.E., Cary R.B., Sauer N.N., and Gupta G. Chemokine regulation in response to beryllium exposure in human peripheral blood mononuclear and dendritic cells. Toxicology 218 (2006) 216-228
15. Ishii Y., and Kitamura S. Elevated levels of soluble ICAM-1 in serum and BAL fluid in patients with active sarcoidosis. Chest 107 (1995) 1636-1640
16. Ito T., Okumura H., Tsukue N., Kobayashi T., Honda K., and Sekizawa K. Effect of diesel exhaust particles on mRNA expression of viral and bacterial receptors in rat lung epithelial L2 cells. Toxicol. Lett. 165 (2006) 66-70
17. Krunkosky T.M., Jordan J.L., Chambers E., and Krause D.C. Mycoplasma pneumoniae host-pathogen studies in an air-liquid culture of differentiated human airway epithelial cells. Microb. Pathog. 42 (2007) 98-103
18. Leung K.H. Release of soluble ICAM-1 from human lung fibroblasts, aortic smooth muscle cells, dermal microvascular endothelial cells, bronchial epithelial cells, and keratinocytes. Biochem. Biophys. Res. Commun. 260 (1999) 734-739
19. Look D.C., Rapp S.R., Keller B.T., and Holtzman M.J. Selective induction of intercellular adhesion molecule-1 by interferon-gamma in human airway epithelial cells. Am. J. Physiol. 263 (1992) L79-L87
20. Melis M., Pace E., Siena L., Spatafora M., Tipa A., Profita M., Bonanno A., Vignola A.M., Bonsignore G., Mody C.H., and Gjomarkaj M. Biologically active intercellular adhesion molecule-1 is shed as dimers by a regulated mechanism in the inflamed pleural space. Am. J. Respir. Crit. Care Med. 167 (2003) 1131-1138
21. Newman L. Current concepts: occupational illness. N. Engl. J. Med. 333 (1995) 1128-1134
22. Newman L., Bobka C., Schumacher B., Daniloff E., Zhen B., Mroz M., and King Jr. T. Compartmentalized immune response reflects clinical severity of beryllium disease. Am. J. Respir. Crit. Care Med. 150 (1994) 135-142
23. Newman L., Kreiss K., King Jr. T., Seay S., and Campbell P. Pathologic and immunologic alterations in early stages of beryllium disease. Am. Rev. Respir. Dis. 139 (1989) 1479-1486
24. Newman L.S. Significance of the blood beryllium lymphocyte proliferation test. Environ. Health Perspect. 104 Suppl. 5 (1996) 953-956
25. Newman L.S., Lloyd J., and Daniloff E. The natural history of beryllium sensitization and chronic beryllium disease. Environ. Health Perspect. 104 Suppl. 5 (1996) 937-943
26. Pforte A., Schiessler A., Gais P., Von Kress S., Beer B., Riethmuller G., and Ziegler-Heitbrock H.W. Expression of the adhesion molecule ICAM-1 on alveolar macrophages and in serum in extrinsic allergic alveolitis. Respiration 60 (1993) 221-226
27. Reddi K., Phagoo S.B., Anderson K.D., and Warburton D. Burkholderia cepacia-induced IL-8 gene expression in an alveolar epithelial cell line: signaling through CD14 and mitogen-activated protein kinase. Pediatr. Res. 54 (2003) 297-305
28. Richeldi L., Sorrentino R., and Saltini C. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science 262 (1993) 242
29. Rossman M.D., Kern J.A., Elias J.A., Cullen M.R., Epstein P.E., Preuss O.P., Markham T.N., and Daniele R.P. Proliferative response of bronchoalveolar lymphocytes to beryllium. A test for chronic beryllium disease. Ann. Intern. Med. 108 (1988) 687-693
30. Saltini C., Winestock K., Kirby M., Pinkston P., and Crystal R.G. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. N. Engl. J. Med. 320 (1989) 1103-1109
31. Sato H., Silveira L., Fingerlin T., Dockstader K., Gillespie M., Lagan A.L., Lympany P., Sawyer R.T., Du Bois R.M., Welsh K.I., and Maier L.A. TNF polymorphism and bronchoalveolar lavage cell TNF-alpha levels in chronic beryllium disease and beryllium sensitization. J. Allergy Clin. Immunol. 119 (2007) 687-696
32. Shrikant P., Chung I.Y., Ballestas M.E., and Benveniste E.N. Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-alpha, interleukin-1 beta, and interferon-gamma in astrocytes. J. Neuroimmunol. 51 (1994) 209-220
33. Striz I., Mio T., Adachi Y., Heires P., Robbins R.A., Spurzem J.R., Illig M.J., Romberger D.J., and Rennard S.I. IL-4 induces ICAM-1 expression in human bronchial epithelial cells and potentiates TNF-alpha. Am. J. Physiol. 277 (1999) L58-L64
34. Takizawa H. Airway epithelial cells as regulators of airway inflammation (review). Int. J. Mol. Med. 1 (1998) 367-378
35. Takizawa H., Abe S., Ohtoshi T., Kawasaki S., Takami K., Desaki M., Sugawara I., Hashimoto S., Azuma A., Nakahara K., and Kudoh S. Diesel exhaust particles up-regulate expression of intercellular adhesion molecule-1 (ICAM-1) in human bronchial epithelial cells. Clin. Exp. Immunol. 120 (2000) 356-362
36. Tamanini A., Rolfini R., Nicolis E., Melotti P., and Cabrini G. MAP kinases and NF-kappaB collaborate to induce ICAM-1 gene expression in the early phase of adenovirus infection. Virology 307 (2003) 228-242
37. Thorley A.J., Ford P.A., Giembycz M.A., Goldstraw P., Young A., and Tetley T.D. Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar type II epithelial cells and macrophages. J. Immunol. 178 (2007) 463-473
38. Tiisala S., Majuri M.L., Carpen O., and Renkonen R. Genistein enhances the ICAM-mediated adhesion by inducing the expression of ICAM-1 and its counter-receptors. Biochem. Biophys. Res. Commun. 203 (1994) 443-449
39. Tinkle S.S., Antonini J.M., Rich B.A., Roberts J.R., Salmen R., Depree K., and Adkins E.J. Skin as a route of exposure and sensitization in chronic beryllium disease. Environ. Health Perspect. 111 (2003) 1202-1208
40. Tinkle S.S., Kittle L.A., and Newman L.S. Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease. J. Immunol. 163 (1999) 2747-2753
41. Tinkle S.S., Kittle L.A., Schumacher B.A., and Newman L.S. Beryllium induces IL-2 and IFN-gamma in berylliosis. J. Immunol. 158 (1997) 518-526
42. Tinkle S.S., and Newman L.S. Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease. Am. J. Respir. Crit. Care Med. 156 (1997) 1884-1891
43. Tinkle S.S., Schwitters P.W., and Newman L.S. Cytokine production by bronchoalveolar lavage cells in chronic beryllium disease. Environ. Health Perspect. 104 Suppl. 5 (1996) 969-971
44. Ulanova M., Puttagunta L., Marcet-Palacios M., Duszyk M., Steinhoff U., Duta F., Kim M.K., Indik Z.K., Schreiber A.D., and Befus A.D. Syk tyrosine kinase participates in beta1-integrin signaling and inflammatory responses in airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 288 (2005) L497-L507
45. Van De Stolpe A., and Van Der Saag P.T. Intercellular adhesion molecule-1. J. Mol. Med. 74 (1996) 13-33